Aligos Therapeutics Inc.

NASDAQ: ALGS · Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Aligos Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-74.18M -53.26M -131.21M -76.95M -75.73M -99.59M -87.68M -81.67M -82.25M -83.39M -96.05M -111.87M -126.38M -136.27M -128.33M -125.04M -125.21M -116.19M
Depreciation & Amortization
1M 1.36M 1.84M 1.94M 2.74M 2.9M 3.07M 3.19M 3.42M 3.54M 3.67M 3.79M 3.85M 3.89M 3.78M 3.65M 3.57M 3.74M
Stock-Based Compensation
5.87M 6.76M 8.45M 9.33M 10.5M 11.64M 12.65M 13.48M 13.77M 14.57M 14.69M 14.93M 15.04M 14.49M 13.46M 11.11M 8.52M 5.13M
Other Working Capital
5.24M -190K -444K -93K -11.46M -11.37M -7.31M -8.38M -5.49M -14.7M -3.27M -7.18M -2.11M 10.61M -4.34M 16.82M 13.74M 11.78M
Other Non-Cash Items
-8.91M -36.05M 43.54M -11.5M 8M 55.85M 37.62M 30.82M 15.4M -435K -159K -61K 10K 58K 86K 116K 11.87M 11.64M
Deferred Income Tax
n/a n/a n/a -4.56M -19.89M -35.14M -35.14M -30.58M -15.25M n/a n/a n/a n/a n/a n/a n/a 331K 492K
Change in Working Capital
993K 1.27M -390K -293K -7.88M -11.35M -9.53M -8.37M -5.01M -15.63M -1.55M -6.87M -838K 11.54M -4.65M 12.3M 11.86M 11.45M
Operating Cash Flow
-74.92M -78.91M -80.74M -85M -85.23M -79.36M -79M -73.12M -69.92M -81.34M -79.39M -100.09M -108.32M -106.3M -115.66M -97.87M -89.06M -83.74M
Capital Expenditures
-206K -104K -130K -109K -95K -81K -19K -103K -94K -435K -943K -1.19M -1.28M -1.1M -892K -617K -864K -1.28M
Cash Acquisitions
n/a n/a n/a n/a -7K n/a n/a -11.7M -44.17M -34.54M -34.54M -22.84M 9.64M n/a n/a n/a n/a n/a
Purchase of Investments
-122.91M -83.6M -108.15M -108.15M -88.57M -88.58M -11K -24.54M -29.5M -44.38M -104.27M -95.88M -93.86M -78.97M -19.09M -2.94M -2K -2K
Sales Maturities Of Investments
70M 110M 90M 70M 40.01M 25.01M 45.01M 81.23M 118.67M 98.92M 78.92M 42.7M 8.24M 13M 23M 38M 62M 67.5M
Other Investing Acitivies
n/a n/a n/a n/a 3K 25M 45M 56.7M 89.18M 54.54M -25.35M -53.19M -85.62M -65.97M 3.91M 35.05M 62M 67.5M
Investing Cash Flow
-53.12M 26.3M -18.28M -38.26M -48.66M -63.65M 44.98M 56.59M 89.08M 54.1M -26.29M -54.38M -86.9M -67.08M 3.02M 34.44M 61.13M 66.22M
Debt Repayment
-48K -64K -83K -44K -60K -91K -96K -65K -72K -54K -61K -108K -102K -92K -79K -71K -67K -65K
Common Stock Repurchased
-461K n/a n/a -572K n/a -350K -350K 222K 111K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -41.03M -41.03M -41.03M
Other Financial Acitivies
321K 438K 438K 88.24M 88.24M 88.4M 88.4M 555K 555K 206K 216K 694K 78.67M 78.67M 78.76M 75.76M -3.14M -3.21M
Financial Cash Flow
101.66M 102.12M 355K 88.19M 88.18M 88.31M 88.33M 513K 515K 184K 164K 595K 78.57M 78.58M 78.68M 271.44M 192.54M 192.47M
Net Cash Flow
-26.38M 49.51M -98.67M -35.06M -45.72M -54.7M 54.31M -16.02M 19.68M -27.05M -105.52M -153.87M -116.65M -94.8M -33.96M 208.01M 164.61M 174.95M
Free Cash Flow
-75.12M -79.01M -80.87M -85.11M -85.33M -79.44M -79.02M -73.22M -70.02M -81.78M -80.33M -101.27M -109.6M -107.4M -116.55M -98.48M -89.93M -85.02M